Time-course of butyric acid-induced differentiation in human K562 leukemic cell line: Rapid increase in γ-globin, porphobilinogen deaminase and NF-E2 mRNA levels

Leukemia

Volumn 11, Issue 9, 1997, Pages 1575-1579

  Chenais B ^a   Molle, I ^a   Trentesaux, C ^a   Jeannesson, P ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Butyric acid; Differentiation; Erythroid genes; GATA 1; Leukemia; NF E2

Indexed keywords

BUTYRIC ACID; ERYTHROPOIETIN RECEPTOR; GAMMA GLOBIN; GLOBIN MESSENGER RNA; MESSENGER RNA; PORPHOBILINOGEN DEAMINASE; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROPOIESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 0030826822     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400755     Document Type: Article

References (24)

1. Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biol 1982; 42: 65-82.
2. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 1975; 45: 321-334.
3. Kawasaki N, Morimoto K, Tanimoto T, Hayakawa T. Control of hemoglobin synthesis in erythroid differentiating K562 cells. Arch Biochem Biophys 1996; 328: 289-294.
4. Chang CS, Sassa S. δ-Aminolevulinate dehydratase in human erythroleukerpia cells: an immunologically distinct enzyme. Blood 1985; 65: 939-944.
5. Fowler DA, Weidner DA, Sommadossi J-P. Effects of 3′-azido-3′deoxythymidine on erythroid inducible gene expression in human K562 leukemia cells. Toxicol Lett 1995; 80: 139-146.
6. Weidner DA, Sommadossi J-P, 3′-Azido-3′-deoxythymidine inhibits globin gene transcription in butyric acid-induced K562 human leukemia cells. Mol Pharmacol 1990; 38: 797-804.
7. Anderson LC, Jokinen M, Gahmberg CG. Induction of erythroid differentiation in the human leukemia cell line K562. Nature 1979; 278: 364-365.
8. Safaya S, Ibrahim A, Rieder RF. Augmentation of γ-globin gene promoter activity by carboxylic acids and components of the human β-globin locus control regions. Blood 1994; 84: 3929-3935.
9. Pace B, Li Q, Peterson K, Stamatoyannopoulos G. α-Amino butyric acid cannot reactivate the silenced γ gene of the β locus YAC transgenic mouse. Blood 1994; 84: 4344-4353.
10. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 1993; 36: 722-728.
11. Andrews NC, Kotkow KJ, Ney PA, Erdjument-Bromage H, Tempst P, Orkin SH. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc Natl Acad Sci USA 1993; 90: 11488-11492.
12. Mignotte V, Eleouet J-F, Raich N, Romeo P-H. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc Natl Acad Sci USA 1989; 86: 6548-6552.
13. Ney PA, Sorrentino BP, Lowrey CH, Nienhuis AW. Inducibility of the HSII enhancer depends on binding of an erythroid specific nuclear protein. Nucleic Acids Res 1990; 18: 6011-6017.
14. Shivdasani RA, Orkin SH. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci USA 1995; 92: 8690-8694.
15. Kotkow KJ, Orkin SH. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol Cell Biol 1995; 15: 4640-4647.
16. Weiss JW, Orkin SH. GATA transcription factors: key regulators of hematopoiesis. Exp Hematol 1995; 23: 99-107.
17. Ngo Nyoung M, Trentesaux C, Aries A, Carpentier Y, Jardillier J-C, Gorisse M-C, Jeannesson P. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. Anticancer Res 1994; 14: 1203-1208.
18. Dean A, Erard F, Schneider AB, Schlechter AN. Induction of hemoglobin accumulation in human K562 cells by hemin is reversible-Science 1981; 212: 459-161.
19. Jeannesson P, Lahlil R, Chénais B, Devy L, Gillet R, Aries A, Morceau F, Trentesaux C. Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression. Leuk Lymphoma (in press).
20. Morceau F, Chénais B, Gillet R, Jardillier J-C, Jeannesson P, Trentesaux C. Transcriptional and post-transcriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells. Cell Growth Differ 1996; 7: 1023-1029.
21. Aries A, Trentesaux C, Ottolenghi S, Jardillier J-C, Jeannesson P, Doubeikovski A. Activation of erythroid specific promoters during anthracycline-induced differentiation of K562 cells. Blood 1996; 87: 2885-2890.
22. Jeannesson P, Trentesaux C, Ngo Nyoung M, Mayeux P, Jacquot R, Jardillier J-C. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells. Leukemia 1991; 5: 14-18.
23. Trentesaux C, Ngo Nyoung M, Aries A, Morceau F, Ronchi A, Ottolenghi S, Jardillier J-C, Jeannesson P. Increased expression of GATA-1 and NF-E2 erythroid transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells. Leukemia 1993; 7: 452-457.
24. Morceau F, Aries A, Lahlil R, Devy L, Jardillier J-C, Jeannesson P, Trentesaux C. Evidence for distinct regulation processes in the aclacinomycin and doxorubicin-mediated differentiation of human erythroleukemic cells. Biochem Pharmacol 1996; 51: 839-845.